Betaxon

Active Ingredient(s): Levobetaxolol
FDA Approved: * February 23, 2000
Pharm Company: * ALCON
Category: Vision / Eye Health

Levobetaxolol is a drug used to lower the pressure in the eye in treating conditions such as glaucoma. It is marketed as a 0.25 or 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon. Levobetaxolol is a beta-adrenergic receptor inhibitor (beta blocker). Contents 1 Indications 2 Effect 3 Contraindications and side effects 4 History 5 References Indications It is indicated for intraocular pressure reduction in patients with open-angle glaucoma or ocular... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.